Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Bavarian Nordic
Pharma
Bavarian Nordic begins commercial launch of mpox vaccine in US
The commercial launch of the mpox vaccine builds on Jynneos’ availability through public health channels since an outbreak in 2022.
Angus Liu
Apr 2, 2024 2:00am
FDA signs off on Valneva's chikungunya vaccine Ixchiq
Nov 10, 2023 9:55am
Mpox still a risk as new awareness campaigns launch
Aug 10, 2023 10:15am
With US deal, BN helps restore supply of smallpox, mpox vaccine
Aug 3, 2023 12:53pm
Bavarian Nordic's mpox vaccine Jynneos up to 86% effective: CDC
May 18, 2023 1:29pm
Emergent sells 3 vaccines to Bavarian Nordic for $270M-plus
Feb 15, 2023 8:56am